Filing Flows

Filing Flows › Companies › Acadia Healthcare Company › Cash flow

Acadia Healthcare Company cash flow, quarter by quarter

Latest: Q3 2026 · from the cash-flow statements filed with the SEC

Free cash flow$47.1M in Q3 2026 · −$23.9M over twelve months

Operating cash flow$97.9M
Capital spending−$50.7M
Free cash flow+$47.1M
Cash / net income2.5×

Analysis

In Q3 2026, Acadia Healthcare Company generated $97.9M of operating cash flow and spent $50.7M on capital projects, leaving free cash flow of $47.1M. That is $110M more than in Q3 2025 (−$63.0M).

Over the twelve months to Sep 30, 2026, operating cash flow was $235M; the largest uses were capital spending ($259M), net borrowing (+) / repaid (−) ($239M), partners ($4.2M); besides operations, cash came from other financing ($281M), asset & business sales ($34.6M); the cash balance rose by $44.6M.

Operating cash flow was $97.9M against net income of $38.6M — 2.5× profit, cash ran ahead of reported earnings. The largest differences: depreciation & amortization +$53.1M, receivables −$30.6M, prepaid and other assets +$13.6M.

Free cash flow

Acadia Healthcare Company: free cash flow by quarterAcadia Healthcare Company: free cash flow by quarter−$86.8MQ4 2024−$163MQ1 2025−$34.2MQ2 2025−$63.0MQ3 2025−$179MQ4 2025−$15.0MQ1 2026$124MQ2 2026$47.1MQ3 2026
Operating cash flow less capital spending.
Acadia Healthcare Company: operating cash flow against capital spendingAcadia Healthcare Company: operating cash flow against capital spendingOperating cash flowCapital spending$117M$203MQ4 2024$11.5M$175MQ1 2025$134M$168MQ2 2025$73.2M$136MQ3 2025−$86.3M$93.2MQ4 2025$61.5M$76.6MQ1 2026$162M$38.6MQ2 2026$97.9M$50.7MQ3 2026
Latest (Q3 2026): Operating cash flow $97.9M, Capital spending $50.7M.

Capital allocation, year by year

Acadia Healthcare Company: where the cash came from (up) and went (down), by fiscal yearAcadia Healthcare Company: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingAsset salesCapital spendingAcquisitionsBuybacksFY2021: Operating cash flow $374MFY2021: Net borrowing −$1.7BFY2021: Asset sales $1.5BFY2021: Capital spending −$245MFY2021: Acquisitions −$139M$1.9BFY2021FY2022: Operating cash flow $381MFY2022: Net borrowing −$114MFY2022: Asset sales $7.1MFY2022: Capital spending −$296MFY2022: Acquisitions −$9.5M$388MFY2022FY2023: Operating cash flow $462MFY2023: Net borrowing −$56.2MFY2023: Asset sales $29.4MFY2023: Capital spending −$424MFY2023: Acquisitions −$349K$492MFY2023FY2024: Operating cash flow $130MFY2024: Net borrowing $279MFY2024: Asset sales $10.4MFY2024: Capital spending −$690MFY2024: Acquisitions −$53.5M$419MFY2024FY2025: Operating cash flow $132MFY2025: Net borrowing −$506MFY2025: Asset sales $23.8MFY2025: Capital spending −$572MFY2025: Acquisitions −$8.2MFY2025: Buybacks −$50.0M$156MFY2025
Over these 5 years operating cash flow totalled $1.5B; the largest uses were net borrowing ($2.3B) and capital spending ($2.2B). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$163M
Debt$2.4B
Net debt$2.2B
Due within a year$28.4M

Acadia Healthcare Company's operations bring cash in ($235M over twelve months), and it spends more than that on capital projects: a gap of $23.9M funded from its $163M of cash and investments and from borrowing ($2.4B of debt, $28.4M due within a year). That is a choice to invest, not a cash runway running down.

Acadia Healthcare Company: debt maturities by year (FY2025)Acadia Healthcare Company: debt maturities by year (FY2025)$28.4MYear 1$32.5MYear 2$495MYear 3$536MYear 4$875MYear 5$550MAfter year 5
Principal due in each year as disclosed in the annual report, against $163M of cash and investments now.

Where the cash came from and went

Acadia Healthcare Company: sources (+) and uses (−) of cash, Q3 2026Acadia Healthcare Company: sources (+) and uses (−) of cash, Q3 2026Operating cash flow$97.9MNet borrowing (+) / repaid (−)−$63.1MCapital spending−$50.7MCash drawn (+) / kept (−)$8.0MAsset & business sales$7.4MPartners−$1.6MOther financing$1.4MOther investing$831K
Acadia Healthcare Company: sources (+) and uses (−) of cash, TTM to Q3 2026Acadia Healthcare Company: sources (+) and uses (−) of cash, TTM to Q3 2026Other financing$281MCapital spending−$259MNet borrowing (+) / repaid (−)−$239MOperating cash flow$235MCash drawn (+) / kept (−)−$44.6MAsset & business sales$34.6MPartners−$4.2MOther investing−$3.4M

From profit to cash

Acadia Healthcare Company: net income to operating cash flow, Q3 2026Acadia Healthcare Company: net income to operating cash flow, Q3 2026Net income$38.6MDepreciation & amortization$53.1MStock-based pay$9.2MDeferred taxes$6.5MImpairments$3.5MGains on disposals$189KOther non-cash$123KReceivables−$30.6MPayables$116KEmployee-related liabilities$6.5MPrepaid and other assets$13.6MOther liabilities−$3.0MOperating cash flow$97.9M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.

Every quarter

QuarterOperating cash flowCapital spendingAcquisitionsBuybacksNet borrowing (+) / repaid (−)Cash drawn (+) / kept (−)Free cash flow
Q3 2026$97.9M−$50.7M——−$63.1M$8.0M$47.1M
Q2 2026$162M−$38.6M——−$113M−$12.8M$124M
Q1 2026$61.5M−$76.6M——−$59.1M−$25.2M−$15.0M
Q4 2025−$86.3M−$93.2M———−$14.5M−$179M
Q3 2025$73.2M−$136M———$12.7M−$63.0M
Q2 2025$134M−$168M$429K−$3.2M—−$40.2M−$34.2M
Q1 2025$11.5M−$175M−$8.6M−$46.9M−$506M−$14.9M−$163M
Q4 2024$117M−$203M——−$15.4M$5.8M−$86.8M

Acadia Healthcare Company: income statement and cash flow

Acadia Healthcare Company, Q3 2026: revenue $895M (+5% year over year), operating margin 6.3%. The chart follows the revenue to costs, profit and cash.

Acadia Healthcare Company: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.